Conversely, the low MOCM group exhibited rich immune cell infiltration and increased expression of MHC class molecules, suggesting a potent anti‐tumour immunity,35 which was corroborated by survival analyses indicating a better prognosis, a finding validated in the OAK immunotherapy cohort. Here, HLA-C is linked to neoplasm.